Thijs Jansz and John Dennis on GLP-1 receptor agonists for kidney outcomes in people with type 2 diabetes
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Thijs Jansz and John Dennis on GLP-1 receptor agonists for kidney outcomes in people with type 2 diabetes
-
Narrated by:
-
By:
Thijs Jansz and John Dennis discuss their Article exploring the comparative effectiveness of GLP-1 receptor agonists versus other agents for kidney outcomes in individuals with type 2 diabetes taking SGLT2 inhibitors, including real-world implications and potential next steps.
Click here to read the full article:
https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(26)00034-8/fulltext
adbl_web_anon_alc_button_suppression_t1
No reviews yet